Soho Flordis International (SFI) is a global natural medicine company committed to identifying and developing leading natural medicines with the best evidence of effectiveness, quality and safety, and marketing them around the world.

SFI is focused on bringing its products to market through healthcare professionals with the endorsement of world class opinion leaders.


SFI is committed to ensuring that people globally have access to quality, innovative evidence based natural medicines. Therefore it is our aim that the safety and efficacy claims for our products are supported by specific clinical evidence. This higher standard enables the selection of safe, appropriate and effective treatments.
View our brands here.


SFI is building an international community of leading herbal and medical companies, experts, scientists and researchers.
View our partners here.


We are committed to further developing the evidence for our products.
View our research programs here.

latest news

SFI Awarded Prestigious ABC’s Tyler Award Given Global Research Effort

Wednesday, March 4, 2015 - 12:33
In recognition of its ongoing commitment to research on natural products to help patients, Soho Flordis International (SFI) has been honored by the American Botanical Council (ABC).

SFI has joined “NSW Leaders”

Friday, February 27, 2015 - 14:10

KeenMind is the Focus of Attention in New Trial

Thursday, January 22, 2015 - 15:25
A new Australian trial will investigate the effects of KeenMind, a unique extract of Bacopa (Bacopa monnieri) CDRI 08, on hyperactivity, inattention and cognition in boys aged between 6 and 14 years.

KeenMind features in Nutraceuticals World

Monday, October 20, 2014 - 15:36
KeenMind features in Nutraceuticals World October 2014 highlighting the numerous randomised, double-blind, placebo-controlled studies that make KeenMind a leader in evidence-based supplementation for cognitive maintenance and improvement.

Ginsana at Vitafoods, presenting the new SFI Group

Wednesday, May 21, 2014 - 00:00
Vitafoods Europe 2014 lived up to its reputation as the most crucial event for the European healthy foods and nutraceuticals sector. Ginsana was there and presented itself for the first time on such an occasion as part of the new SFI Group.